Cerberus Therapeutics

Cerberus Therapeutics

Edit info

  • Founded: 2022
  • Location: Cambridge, MA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Autoimmune conditions
  • Drug types: IMM, ONC
  • Lead product: Undisclosed


cerberustx.com

linkedin.com


Drug notes:

Undisclosed RD infectious diseases

About:

Cerberus Therapeutics, based in Boston, Massachusetts, uses alpaca-derived nanobodies to develop autoimmune and infectious disease therapies. Novalia Pishesha, Hidde Ploegh, and Harvey Lodish founded Cerberus Therapeutics in 2021. Their nanobody-based platforms drive the development of durable, potent, and protective immune responses.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com